Evidence map›Paper›PMID 32690498›Full record

ArticleBMJ open2020

Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review.

Melissa Mialon, Stefanie Vandevijvere, Angela Carriedo-Lutzenkirchen, Lisa Bero, Fabio Gomes, Mark Petticrew, Martin McKee, David Stuckler, Gary Sacks

Abstract readScoping Review
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed.

  1. Underinvestment, Corporate Power and Health Promotion's Moral Jeopardy.Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Do ESG Frameworks Capture Corporate Health Impacts? An Analysis of the Food and Beverage Industry.International journal of environmental research and public health · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. The attributes of public health leadership.European journal of public health · 2025
    Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Melissa MialonSchool of Public Health, University of Sao Paulo, Sao Paulo, Brazil melissa_mialon@hotmail.fr.ORCID 0000-0002-9883-6441
Stefanie VandevijvereSciensano, Brussels, Brussels, Belgium.
Angela Carriedo-LutzenkirchenWorld Public Health Nutrition Association, London, UK.
Lisa BeroCharles Perkins Centre and School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Fabio GomesPan American Health Organization, Washington, District of Columbia, USA.
Mark PetticrewFaculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, London, UK.
Martin McKeeFaculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, London, UK.ORCID 0000-0002-0121-9683
David StucklerDondena Research Centre and Department of Policy Analysis and Public Management, Bocconi University, Milano, Lombardia, Italy.
Gary SacksGlobal Obesity Centre, Deakin University, Burwood, Victoria, Australia.

Funding

Wellcome Trust
6 · The paper itself

Abstract

objectiveWe identified mechanisms for addressing and/or managing the influence of corporations on public health policy, research and practice, as well as examples of where these mechanisms have been adopted from across the globe.

designWe conducted a scoping review. We conducted searches in five databases on 4 June 2019. Twenty-eight relevant institutions and networks were contacted to identify additional mechanisms and examples. In addition, we identified mechanisms and examples from our collective experience working on the influence of corporations on public health policy, research and practice.

settingWe identified mechanisms at the national, regional and global levels.

resultsThirty-one documents were included in our review. Eight were peer-reviewed scientific articles. Nine discussed mechanisms to address and/or manage the influence of different types of industries; while other documents targeted specific industries. In total, we identified 49 mechanisms for addressing and/or managing the influence of corporations on public health policy, research and practice, and 43 of these were adopted at the national, regional or global level. We identified four main types of mechanisms: transparency; management of interactions with industry and of conflicts of interest; identification, monitoring and education about the practices of corporations and associated risks to public health; prohibition of interactions with industry. Mechanisms for governments (n=17) and academia (n=13) were most frequently identified, with fewer for the media and civil society.

conclusionsWe identified several mechanisms that could help address and/or manage the negative influence of corporations on public health policy, research and practice. If adopted and evaluated more widely, many of the mechanisms described in this manuscript could contribute to efforts to prevent and control non-communicable diseases. TRIAL REGISTRATION DETAILS: The protocol was registered with the Open Science Framework on 27 May 2019 (https://osf.io/xc2vp).

Indexed as

Health PolicyCommerceConflict of InterestHumansIndustryPoliticsPublic Healthcommercial determinants of healthcorporate political activitypublic policy

Identifiers

PMID32690498
PMCPMC7371213

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.